Use of low-level laser therapy as monotherapy or concomitant therapy for male and female androgenetic alopecia
Munck A, Gavazzoni MF, Trüeb RM
International journal of trichology · 39 citations
Review labels
Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.
How it was studied
- Design
- Cohort study (classified by our AI screen)
- Studied in
- People
- Main outcome
- Health markers and function
Who paid for it
- Funding
- Funding not disclosed
Publication
- Published
- 2014-01-01 · Int J Trichology · vol. 6 · issue 2 · p. 45
- Publisher
- Medknow
- Cited
- 65 citations · more than 98% of similar papers · 6.9× the field average
- Impact
- Top 10% most cited in its field
- References
- 15 works
- Access
- Open access (repository copy) · CC-BY-NC-SA
- Research areas
- Hair Growth and Disorders · Dermatologic Treatments and Research · Facial Rejuvenation and Surgery Techniques
- Keywords
- Concomitant, Finasteride, Medicine, Combination therapy, Adverse effect, Laser therapy, Minoxidil, Pharmacotherapy, Urology, Dermatology, Internal medicine, Laser
3 authors
- RalphM Trüeb
- Andréia Munck · corresponding
- MariaFernanda Gavazzoni
Abstract
Background
Androgenetic alopecia (AGA) is the most common form of hair loss in men and in women. Currently, minoxidil and finasteride are the treatments with the highest levels of medical evidence, but patients who exhibit intolerance or poor response to these treatments are in need of additional treatment modalities.
Objective
The aim was to evaluate the efficacy and safety of low-level laser therapy (LLLT) for AGA, either as monotherapy or as concomitant therapy with minoxidil or finasteride, in an office-based setting.
Materials and methods
Retrospective observational study of male and female patients with AGA, treated with the 655 nm-HairMax Laser Comb(®), in an office-based setting. Efficacy was assessed with global photographic imaging.
Results
Of 32 patients (21 female, 11 male), 8 showed significant, 20 moderate, and 4 no improvement. Improvement was seen both with monotherapy and with concomitant therapy. Improvement was observed as early as 3 months and was sustained up to a maximum observation time of 24 months. No adverse reactions were reported.
Conclusions
LLLT represents a potentially effective treatment for both male and female AGA, either as monotherapy or concomitant therapy. Combination treatments with minoxidil, finasteride, and LLLT may act synergistic to enhance hair growth.
Abstract via Europe PMC. Copyright remains with the authors or publisher (CC BY-NC-SA).
Community trust
Loading…
How much do you trust this study's findings?
Comments
Sign in to rate, comment on or flag this study.Sign inSomething wrong here?
Flag this study if its information, labels or funding look wrong. An editor reviews every flag.
Sign in to rate, comment on or flag this study.Sign inEducational information about published research. Not medical advice, and not a recommendation to start or stop anything.